Feline ocular toxoplasmosis

Veterinary Ophthalmology

Volumn 1, Issue 2-3, 1998, Pages 71-80

  Davidson, M G ^a   English, R V ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Animal Eye Clinic   (United States)

Author keywords

Anterior uveitis; Chorioretinitis; Feline; Ocular immunology; Toxoplasmosis

Indexed keywords

ANIMALIA; FELIDAE; FELIS CATUS; TOXOPLASMA GONDII;

EID: 0002875508     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5224.1998.00033.x     Document Type: Review

References (72)

1. Dubey JP, Toxoplasmosis of Animals and Man. CRC Press, Boca Raton, FL1988.
2. Dubey JP. Toxoplasmosis. Journal of the American Veterinary Medical Association 1994; 205: 1593-1598.
3. Dubey JP. Persistence of Toxoplasma gondii in the tissues of chronically infected cats. Journal of Parasitology 1977; 63: 156-157.
4. Dubey JP. Toxoplasmosis in cats. Feline Practice 1986; 16: 12-26.
5. Frenkel JK, Dubey JP. Toxoplasmosis and its prevention in cats and man. Journal of Infectious Disease 1972; 126: 664-673.
6. Dubey JP. Attempted transmission of feline coccidia from chronically infected queens to their kittens. Journal of the American Veterinary Medical Association 1977; 170: 541-543.
7. Lappin M, Greene C, Prestwood A, Dawe D, Marks A. Prevalence of Toxoplasma gondii infection in cats in Georgia using enzyme-linked immunosorbent assays for IgM, IgG antigens. Veterinary Parasitology 1989; 33: 225-230.
8. Frenkel JK. Toxoplasmosis in cats and man. Feline Practice 1975; 5: 28-41.
9. Dubey JP, Johnston I. Fatal neonatal toxoplasmosis. Journal of the American Animal Hospital Association 1982; 18: 461-467.
10. Lappin MR, Greene CE, Winston S, et al. Clinical feline toxoplasmosis: serologic and therapeutic management of 15 cases. Journal of Veterinary Internal Medicine 1989; 3: 139-143.
11. Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats.100 cases 1952-90. Journal of the American Veterinary Medical Association; 203: 1993.
12. Holland GN, O'Connor GR, Belfort R, Remington JS. Toxoplasmosis. In: Ocular Infection, Immunity, (eds Pepose JS, Holland GN, Wilhelmus KR) CV Mosby, St Louis, 1996: 1183-1224.
13. Perkins ES. Ocular toxoplasmosis. British Journal of Ophthalmology 1973; 57: 1-7.
14. Glasner PD, Silveira C, Kruszon-Moran D et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. American Journal of Ophthalmology 1992; 114: 136-144.
15. Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. American Journal of Ophthalmology 1988; 106: 362-364.
16. Holland GN, Engstrom RE, Glasgow BJ. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. American Journal of Ophthalmology 1988; 106: 653-667.
17. Campbell LH. Toxoplasma retinitis in a cat. Feline Practice 1974; 4: 36-39.
18. Vanisi SJ, Campbell LH. Ocular toxoplasmosis in cats. Journal of the American Veterinary Medical Association 1969; 154: 141-152.
19. Heeley DM. Toxoplasmosis. Journal of Small Animal Practice 1963; 4: 435-436.
20. Hirth RS, Nielsen SW. Pathology of feline toxoplasmosis. Journal of Small Animal Practice 1969; 10: 213-221.
21. Petrak M, Carpenter J. Feline toxoplasmosis. Journal of the American Veterinary Medical Association 1965; 146: 728-734.
22. Davidson MG, Nasisse MP, English RV. Feline anterior uveitis: a study of 53 cases. Journal of the American Animal Hospital Association 1991; 27: 77-83.
23. Lappin MR, Marks A, Greene CE, et al. Serologic prevalence of selected infectious diseases in cats with uveitis. Journal of the American Veterinary Medical Association 1992; 210: 1005-1009.
24. Piper RC, Cole CR, Shadduck JA. Natural and experimental ocular toxoplasmosis in animals. American Journal of Ophthalmology 1970; 69: 662-668.
25. Chavkin M, Lappin MR, Powell CC. et al. Seroepidemiologic and clinical observation of 93 cases of uveitis in cats. Progress in Veterinary and Comparative Ophthalmology 1992; 2: 29-36.
26. Davidson MG, Lappin MG, English RV, Tompkins MA. A feline model of ocular toxoplasmosis. Investigative Ophthalmology and Visual Science 1993; 34: 3653-3660.
27. Davidson MG, Lappin MR, Rottman JR et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. 1996; 40: 1352-1359.
28. Davidson MG, English RV, Rottman J et al. Feline immunodeficiency virus predisposes cats to secondary acute generalized toxoplasmosis: a model for AIDS. American Journal of Pathology 1993; 143: 1486-1497.
29. Lappin MR, Roberts SM, Davidson MG et al. Enzyme linked immunosorbent assays for the detection of Toxoplasma gondii-specific antibodies and antigens in the aqueous humor of cats. Journal of the American Veterinary Medical Association 1992; 201: 1010-1016.
30. Lappin MR, Cayatte S, Powell CC et al. Detection of Toxoplasma gondii antigen-containing immune complexes in the serum of cats. American Journal of Veterinary Research 1993; 54: 415-419.
31. Lappin MR, Burney DP, Dow SW, Potter TA. Polymerase chain reaction for the detection of Toxoplasma gondii in aqueous humor of cuts. American Journal of Veterinary Research 1996; 157: 1589-1593.
32. Peiffer RL. Letters to the editor. Progress in Veterinary and Comparative Ophthalmology 1992; 2: 126-127.
33. Peiffer RL, Wilcock BP. Histopathologic study of uveitis in cats. 139 Cases 1978-88. Journal of the American Veterinary Medical Association; 1991: 135-138.
34. Wilcock BP, Peiffer RL, Davidson MG. The causes of glaucoma in cats. Veterinary Pathology 1990; 27: 439-442.
35. Lin DS, Bowman DD. Cellular responses of cats with primary toxoplasmosis. Journal of Parasitology 1991; 77: 272-279.
36. Suzuki Y, Conley FK, Remington JS. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infection and Immunity 1990; 58: 3050-3055.
37. Whitt CJ, Moench TR, Gittelsohn AM et al. Epidemiologic observations in FIV and T. gondii coinfection in cats in Baltimore. Journal of the American Veterinary Medical Association 1989; 194: 229-233.
38. O'Neill SA, Lappin MR, Reif JS et al. Clinical and epidemiological aspects of feline immunodeficency virus and Toxoplasma gondii coinfections in cats. Journal of the American Animal Hospital Association 1991; 27: 211-220.
39. Zimmerman LE. Ocular pathology of toxoplasmosis. Survey of Ophthalmology 1961; 6: 832-867.
40. Frenkel JK, Escajadillo A. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. American Journal of Medical Hygiene 1987; 36: 517-522.
41. de Boer JH, Verhagen C, Bruinenberg M et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. American Journal of Ophthalmology 1996; 121: 650-658.
42. Nussenblatt RB, Gery I, Ballintine EJ, et al. Cellular immune responsiveness of uveitis patients to retinal S-antigen. American Journal of Ophthalmology 1980; 89: 173-179.
43. Nussenblatt RB, Belfort R Jr Ocular toxoplasmosis. An old disease revisited. Journal of the American Medical Association 1994; 271: 304-307.
44. Rehder JR, Burnier MB Jr, Pavesio CE et al. Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. American Journal of Ophthalmology 1988; 106: 740-741.
45. Chavkin MJ, Lappin MR, Powell CC, Cooper CM, Muñana KR, Howard LH. Toxoplasma gondii specific antibodies in the serum and aqueous humor of cats with experimental toxoplasmosis. American Journal of Veterinary Research 1994; 55: 1244-1249.
46. Saari KM, Hakli J, Solja J et al. HLA-B27 frequency and MLC reactions in acute anterior uveitis. Albrecht Von Graefe's Archives Klin Ophthalmology 1981; 216: 23-29.
47. Singh VK, Kalra HK, Yamaki K, Abe T, Donoso LA, Shinohara T. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. Journal of Immunology 1990; 144: 1282-1287.
48. Singh VK, Yamaki K, Donoso LA, Shinohara T. Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis. Journal of Immunology 1989; 142: 1512-1517.
49. Karray S, Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proceedings of the National Academy of Science of the USA 1997; 94: 1356-1360.
50. Andersson MA, Bergstrom TB, Blomstrand C, Hermodsson SH, Hakansson C, Lowhagen GB. Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection. Journal of Neuroimmunology 1988; 19: 291-304.
51. Mizuma H, Litwin S, Zolla-Pazner S. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clinical and Experimental Immunology 1988; 71: 410-416.
52. English RV, Nelson P, Johnson CM, Nasisse M, Tompkins WA, Tompkins MB. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. Journal of Infectious Disease 1994; 170: 543-552.
53. Dubey JP. Diagnosis of feline toxoplasmosis. Feline Practice 1973; 3: 14-17.
54. Dubey JP, Thulliez P. Serologic diagnosis of toxoplasmosis in cats fed T. gondii tissue cysts. Journal of the American Veterinary Medical Association 1989; 194: 1297-1299.
55. Lappin MR, Greene CE, Prestwood AK, et al. Diagnosis of recent Toxoplasma gondii infection in cats by use of ELISA for IgM. American Journal of Veterinary Research 1989; 50: 1580-1586.
56. Dubey JP, Lappin MR, Thulliez P. Long term antibody responses of cats fed Toxoplasma gondii tissue cysts. Journal of Parasitology 1995; 81: 887-893.
57. Lappin MR, Macks A, Greene CE. Effect of FIV infection on Toxoplasma gondii specific humoral and cell medicated immune responses in cats with serologic evidence of toxoplasmosis. Journal of Veterinary Internal Medicine 1993; 71: 95-10057.
58. Lin DS, Bowman DD, Jacobson RH. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections. Journal of Clinical Microbiology 1992; 30: 17-24.
59. Lappin MR, Chavkin MJ, Munana KR, Cooper CM. Feline ocular and cerebrospinal fluid Toxoplasma gondii-specific humoral immune responses following specific and nonspecific immune stimulation. Veterinary Immunology and Immunopathology 1996; 55: 23-31.
60. Hill SL, Lappin MR, Carman J et al. Comparison of methods for estimation of Toxoplasma gondii-specific antibody production in the aqueous humor of cats. American Journal of Veterinary Research 1995; 56: 1181-1186.
61. Stiles J, Prade R, Greene C. Detection of Toxoplasma gondii in feline and canine biological samples by use of polymerase chain reaction. American Journal of Veterinary Research 1996; 57: 264-267.
62. Pfefferkorn ER, Nothnagel RF, Borotz SE. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrobial Agents and Chemotherapy 1992; 36: 1091-1096.
63. Araujo FG, Remington JS. Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrobial Agents and Chemotherapy 1974; 5: 647-651.
64. Tabbara KF, Nozik RA, O'Connor R. Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Archives of Ophthalmology 1974; 92: 244-247.
65. Lakhanpal V, Schocket SS, Nirankari VS. Clindamycin in the treatment of toxoplasmic retinochoroiditis. American Journal of Ophthalmology 1983; 95: 605-613.
66. Engstrom RE, Holland RB, Nussenblatt RB, Jabs DA. Current practices in the management of ocular toxoplasmosis. American Journal of Ophthalmology 1991; 111: 601-610.
67. Araujo FG, Lin T, Remington JS. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine. Journal of Infectious Disease 1993; 167: 494-497.
68. Araujo FG, Huskinson J, Remington JS. Remarkable in vitro and in vivo activities of Hydroxynapthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 1991; 35: 293-299.
69. Dubey JP, Yeary RA. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii. Canadian Veterinary Journal 1977; 18: 51-57.
70. Dubey JP. Reshedding of Toxoplasma oocysts by chronically infected cats. Nature 1976; 262: 213-214.
71. Dubey JP, Frenkel JK. Immunity to toxoplasmosis: modulation by ad-ministration of corticosteriods. Veterinary Pathology 1974; 11: 350-379.
72. Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. Journal of Parasitology. 1995; 8: 406-415.